$0.69
2.56% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US63008J1088
Symbol
NAOV

NanoVibronix, Inc. Stock price

$0.69
+0.14 26.01% 1M
-0.09 11.34% 6M
-0.46 40.17% YTD
-0.68 49.78% 1Y
-23.31 97.13% 3Y
-56.61 98.80% 5Y
-69.31 99.02% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.02 2.56%
ISIN
US63008J1088
Symbol
NAOV
Sector

Key metrics

Market capitalization $2.58m
Enterprise Value $1.40m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.43
P/S ratio (TTM) P/S ratio 0.78
P/B ratio (TTM) P/B ratio 1.02
Revenue (TTM) Revenue $3.29m
EBIT (operating result TTM) EBIT $-2.91m
Free Cash Flow (TTM) Free Cash Flow $-2.46m
Cash position $1.31m
EPS (TTM) EPS $-1.23
Short interest 4.71%
Show more

Is NanoVibronix, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

NanoVibronix, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast NanoVibronix, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast NanoVibronix, Inc.:

Buy
100%

Financial data from NanoVibronix, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
3.29 3.29
102% 102%
100%
- Direct Costs 1.33 1.33
46% 46%
40%
1.96 1.96
172% 172%
60%
- Selling and Administrative Expenses 4.26 4.26
130% 130%
129%
- Research and Development Expense 0.62 0.62
114% 114%
19%
-2.91 -2.91
50% 50%
-88%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -2.91 -2.91
50% 50%
-89%
Net Profit -3.09 -3.09
47% 47%
-94%

In millions USD.

Don't miss a Thing! We will send you all news about NanoVibronix, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NanoVibronix, Inc. Stock News

Neutral
Business Wire
about 2 months ago
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (“SAW”) Portable Ultrasonic Therapeutic Devices, today announced it has signed a non-binding term sheet for a license and supply agreement with APOGEPHA Arzneimittel GmbH (“APOGEPHA”), a German pharmaceutic...
Neutral
Business Wire
2 months ago
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a letter of intent with Medici Medical LTD (“Medici”), a leading distributor of medical products in the Israeli healthcare market...

Company Profile

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.

Head office United States
CEO Brian Murphy
Employees 16
Founded 2003
Website www.nanovibronix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today